Kinlaw Alan C, Stürmer Til, Lund Jennifer L, Pedersen Lars, Kappelman Michael D, Daniels Julie L, Frøslev Trine, Mack Christina D, Sørensen Henrik Toft
Cecil G. Sheps Center for Health Services Research,
Departments of Epidemiology and.
Pediatrics. 2017 Sep;140(3). doi: 10.1542/peds.2017-0441. Epub 2017 Aug 14.
We examined 2 birth cohort effects on antibiotic prescribing during the first year of life (henceforth, infancy) in Denmark: (1) the birth season effect on timing and overall occurrence of antibiotic prescribing, and (2) the birth year effect amid emerging nationwide pneumococcal vaccination programs and changing prescribing guidelines.
We linked data for all live births in Denmark from 2004 to 2012 ( = 561 729) across the National Health Service Prescription Database, Medical Birth Registry, and Civil Registration System. Across birth season and birth year cohorts, we estimated 1-year risk, rate, and burden of redeemed antibiotic prescriptions during infancy. We used interrupted time series methods to assess prescribing trends across birth year cohorts. Graphical displays of all birth cohort effect data are included.
The 1-year risk of having at least 1 redeemed antibiotic prescription during infancy was 39.5% (99% confidence interval [CI]: 39.3% to 39.6%). The hazard of a first prescription increased with age throughout infancy and varied by season; subsequently, Kaplan-Meier-derived risk functions varied by birth season cohort. After rollout of a first vaccination program and new antibiotic prescribing guidelines, 1-year risk decreased by 4.4% over 14 months (99% CI: 3.4% to 5.5%); it decreased again after rollout of a second vaccination program by 6.9% over 3 years (99% CI: 4.4% to 9.3%).
In Denmark, birth season and birth year cohort effects influenced timing and risk of antibiotic prescribing during infancy. Future studies of antibiotic stewardship, effectiveness, and safety in children should consider these cohort effects, which may render some children inherently more susceptible than others to downstream antibiotic effects.
我们考察了丹麦出生队列对出生后第一年(以下简称婴儿期)抗生素处方的两个影响:(1)出生季节对抗生素处方时间和总体发生率的影响,以及(2)在全国范围内新兴的肺炎球菌疫苗接种计划和不断变化的处方指南背景下出生年份的影响。
我们将丹麦2004年至2012年所有活产(n = 561729)的数据与国家卫生服务处方数据库、医学出生登记处和民事登记系统进行了关联。在出生季节和出生年份队列中,我们估计了婴儿期 redeemed 抗生素处方的1年风险、发生率和负担。我们使用中断时间序列方法来评估出生年份队列中的处方趋势。文中包含了所有出生队列效应数据的图形展示。
婴儿期至少有1张 redeemed 抗生素处方的1年风险为39.5%(99%置信区间[CI]:39.3%至39.6%)。在整个婴儿期,首次处方的风险随着年龄增长而增加,且因季节而异;随后,通过Kaplan-Meier法得出的风险函数因出生季节队列而异。在首个疫苗接种计划和新的抗生素处方指南推出后,1年风险在14个月内下降了4.4%(99%CI:3.4%至5.5%);在第二个疫苗接种计划推出后,又在3年内下降了6.9%(99%CI:4.4%至9.3%)。
在丹麦,出生季节和出生年份队列效应影响了婴儿期抗生素处方的时间和风险。未来关于儿童抗生素管理、有效性和安全性的研究应考虑这些队列效应,这些效应可能使一些儿童比其他儿童更容易受到下游抗生素效应的影响。